- This event has passed.
NRC’s Human Health Therapeutics Programs Recharge
November 16, 2018
On Friday, November 16, 2018, LifeSciences BC held the NRC’s Human Health Therapeutics Programs Recharge.
The National Research Council Canada Human Health Therapeutics (NRC-HHT) programs have recently been refreshed to incorporate a new NRC collaboration model that includes grants and contributions.
Recently announced “NRC Health Challenge Program” is being scoped around the theme of engineered cell- and gene-based therapy development and delivery, in broad consultations with Canadian academia, hospitals and business communities. The NRC Health Challenge Program’s three main thrusts are: 1) next-generation chimeric antigen receptors (CARs); 2) induced pluripotent stem cell (iPSC) technologies; and 3) in vivo genome editing.
Academia and industry were encouraged to attend this event to provide NRC with their input into the program development and discuss future engagements.
The NRC-HHT Research Centre works hand in hand with industry to help biotech firms achieve success. As an R&D partner of choice, the NRC-HHT Research Centre de‑risks critical steps in the development of biologics, vaccines, and delivery of large molecules to the brain, to help improve the health of Canadians. NRC-HHT adds value to collaborators’ products and accelerates their progress to market by overcoming challenges in preclinical development and product characterization, optimizing bioprocesses and their scale-up, and developing biomarkers.
Success stories were presented on the co-development model used by Canadian biotechs that have partnered with NRC to accelerate their innovative biologic products development and the new assets in development.
Event Schedule:
9:00am – Intro Presentation from LSBC: Dr. Lesley Esford, President & CEO, LSBC
Intro from NRC: Eileen Raymond, Business Advisor, Business Management Support unit, NRC
9:15am – ‘NRC Advanced Biologics and Biomanufacturing Program’
Presenter: Dr. Lynne LeSauteur, R&D Director, Downstream Processing and Analytics, and Program Leader, Biologics and Biomanufacturing, NRC
NRC is seeking new opportunities for co-development of biologics for cancer and CNS diseases, vaccines for unmet needs and enabling technologies
9:35am – ‘NRC Genomics Expertise and Deep Learning Approaches’
Presenter: Dr. Simon Drouin, Team Leader, Applied Genomics, NRC
NRC is seeking to leverage their applied genomics expertise and capacities for gene- and cell-based therapy development
9:45am – Questions and Networking break
10:15am – NRC Health Challenge Program:
‘Transforming Health Outcomes through Engineered Cell and Gene Therapies’
Presenter: Dr. Danica Stanimirovic, Director of Translational Bioscience Department and Interim Program Director, NRC Health Challenge Program
NRC is seeking to engage discussions on the collaborative opportunities for this program focussing on disruptive technologies applied to next generation of engineered cell and gene therapies
10:45am – Open discussion and Networking
11:30am – End of session